RhumbLine Advisers’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,594
Closed -$67K 4200
2025
Q1
$67K Buy
15,594
+833
+6% +$3.58K ﹤0.01% 3500
2024
Q4
$316K Buy
14,761
+1,652
+13% +$35.3K ﹤0.01% 2964
2024
Q3
$247K Sell
13,109
-122
-0.9% -$2.3K ﹤0.01% 3132
2024
Q2
$300K Buy
+13,231
New +$300K ﹤0.01% 3006